5 Most Undervalued Blue Chip Stocks to Invest In

Page 1 of 5

In this article, we will list the 5 Most Undervalued Blue Chip Stocks to Invest In. Please visit 7 Most Undervalued Blue Chip Stocks to Invest In if you would like to see the extended list and the methodology behind it.

General Motors Company (GM)'s CEO Should Be Worried, Says Jim Cramer

5. Medtronic plc (NYSE:MDT)

On March 23, 2026, Medtronic plc (NYSE:MDT) received U.S. FDA approval for an expanded indication for its OmniaSecure defibrillation lead, now allowing placement in the left bundle branch area for conduction system pacing. The company said this approach more closely mimics the heart’s natural physiology, with additional benefits for patients requiring cardiac resynchronization through combined pacing techniques.

On March 10, 2026, Medtronic plc (NYSE:MDT) announced a definitive agreement to acquire Scientia Vascular for $550M, with potential additional earn-out payments. The company said the deal, expected to close in the first half of FY27, will be minimally dilutive to adjusted EPS in FY27 and accretive thereafter. Scientia operates in Salt Lake City with approximately 310 employees.

Last month, Medtronic plc (NYSE:MDT) reported Q3 EPS of $1.36, above the $1.34 consensus estimate, on revenue of $9.02B versus $8.89B expected. CEO Geoff Martha said the company delivered “strong” performance with 6% organic revenue growth, highlighting continued investment in innovation and expansion into new markets to support long-term growth.

Medtronic plc (NYSE:MDT) develops and manufactures medical devices and therapies used across a range of healthcare applications.

Page 1 of 5